0001354488-13-005551.txt : 20131003
0001354488-13-005551.hdr.sgml : 20131003
20131003164925
ACCESSION NUMBER: 0001354488-13-005551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131001
FILED AS OF DATE: 20131003
DATE AS OF CHANGE: 20131003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERNIX THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001024126
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330724736
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33219 FOREST WEST STREET
CITY: MAGNOLIA
STATE: TX
ZIP: 77354
BUSINESS PHONE: (832) 934-1825
MAIL ADDRESS:
STREET 1: 33219 FOREST WEST STREET
CITY: MAGNOLIA
STATE: TX
ZIP: 77354
FORMER COMPANY:
FORMER CONFORMED NAME: GOLF TRUST OF AMERICA INC
DATE OF NAME CHANGE: 19961002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Cooper C.
CENTRAL INDEX KEY: 0001485508
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14494
FILM NUMBER: 131134331
MAIL ADDRESS:
STREET 1: 33219 FOREST WEST DRIVE
CITY: MAGNOLIA
STATE: TX
ZIP: 77354
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2013-10-01
0
0001024126
PERNIX THERAPEUTICS HOLDINGS, INC.
PTX
0001485508
Collins Cooper C.
33219 FOREST WEST DR
MAGNOLIA
TX
77354
1
1
1
Chief Strategic Officer
Common Stock
2013-10-01
4
S
0
27736
2.6145
D
6602310
D
Common Stock
2013-10-02
4
S
0
13200
2.5689
D
6589110
D
Common Stock
2013-10-03
4
S
0
25700
2.4635
D
6563410
D
Common Stock
245163
I
Spouse
Common Stock
390681
I
GRAT
Common Stock
390681
I
Spousal GRAT
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/26/13.
The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.67, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.61, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.54, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/Cooper C. Collins
2013-10-03